View in EDS HTML Full Text PDF Full Text

A Five‐Year Prospective, Randomized, Open‐Label Study of Standard‐Dose Versus Low‐Dose Prolonged‐Release Tacrolimus With or Without Angiotensin‐Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker Post Kidney Transplantation

Saved in:
Bibliographic Details
Title: A Five‐Year Prospective, Randomized, Open‐Label Study of Standard‐Dose Versus Low‐Dose Prolonged‐Release Tacrolimus With or Without Angiotensin‐Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker Post Kidney Transplantation
Authors: Campbell, Patricia M.1 (AUTHOR), Cantarovich, Marcelo2 (AUTHOR), Gangji, Azim3 (AUTHOR), Houde, Isabelle4 (AUTHOR), Jevnikar, Anthony M.5 (AUTHOR), Monroy‐Cuadros, Felix‐Mauricio6 (AUTHOR), Nickerson, Peter W.7 (AUTHOR), Pâquet, Michel R.8 (AUTHOR), Prasad, G. V. Ramesh9 (AUTHOR), Senécal, Lynne10 (AUTHOR), Wolff, Jean‐Luc11 (AUTHOR), Schwartz, Jason J.12 (AUTHOR), Rush, David N.7 (AUTHOR) DRush@hsc.mb.ca
Source: Clinical Transplantation. Jan2025, Vol. 39 Issue 1, p1-9. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09020063
DOI:10.1111/ctr.70067